Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 10/2014

01-10-2014 | Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (EM Venditti, Section Editor)

Lifestyle Management for Enhancing Outcomes after Bariatric Surgery

Authors: Melissa Kalarchian, Melanie Turk, Jennifer Elliott, William Gourash

Published in: Current Diabetes Reports | Issue 10/2014

Login to get access

Abstract

Bariatric surgery has been safe and effective for treatment of severe obesity and comorbidities like type 2 diabetes mellitus (T2D). Nonetheless, weight loss and health outcomes vary considerably across individuals. Although the factors associated with outcomes are not fully understood, postoperative weight loss following any type of bariatric surgery is largely dependent on the extent to which patients can make and sustain changes in eating and activity. Therefore, lifestyle management including diet, exercise, and behavior modification is critical to helping patients achieve long-term weight loss. Pharmacotherapy and reoperation may also play a role after bariatric surgery. In this article, we highlight recent research findings in all of these areas to provide suggestions for how to enhance outcomes following bariatric surgery. Research on the mechanisms for weight loss and improvements in T2D following the different surgical procedures is needed to support the development of more personalized approaches to the multidisciplinary management of severe obesity.
Literature
1.
Consensus Development Conference Panel. NIH conference: gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956–61.CrossRef
2.
3.
4.
Buchwald H. Consensus conference statement: bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005;1(3):371–81.PubMedCrossRef
5.
Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14 Suppl 1:1–93.PubMedCrossRef
6.
Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet. 2014;2:152–64.PubMed
7.
DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6(4):347–55.
8.
9.
Flum D, Belle S, Berk P, Chapman W, Courcoulas A, King W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.PubMedCrossRef
10.••
Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25. This paper documents that bariatric surgery is associated with significant weight loss and health improvements at 3-year follow-up in a relatively large and diverse national sample.
11.
Coleman K, Haung Y, Hendee F, Watson H, Casillas R, Brookey J. Three-year weight outcomes from a bariatric surgery registry in a large integrated healthcare system. Surg Obes Relat Dis. 2014;10(3):403–4.CrossRef
12.
Gloy V, Briel M, Bhatt D, Kashyap SR, Schafer P, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934.PubMedPubMedCentralCrossRef
13.
Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36.PubMedPubMedCentral
14.
Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.PubMedCrossRef
15.
Courcoulas A, Goodpaster BH, Eagleton JK, Belle SH, Kalarchian MA, Lang W, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014. Epub ahead of print.
16.
Maggard-Gibbons M, Maglione ML, Masha, Ewing B, Ruelaz A, Hu J, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes a systematic review. JAMA. 2013;309(21):2250–61.PubMedCrossRef
17.
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer S, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes 3-year outcomes. N Engl J Med. 2014;370(21):2002–13.PubMedCrossRef
18.
19.
Sjoholm K, Anveden A, Peltonen M, Romeo S, Svensson PA, Sjostrom L, et al. Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish Obese Subjects (SOS) study. Diabetes Care. 2013;36(5):1335–40.PubMedPubMedCentralCrossRef
20.
Sjostrom L, Lindroos A, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–753.PubMedCrossRef
21.
Still C, Wood C, Chu X, Manney C, Strodel W, Petrick A, et al. Clinical factors associated with weight loss outcomes after Roux-en-Y gastric bypass surgery. Obesity. 2014;22:888–94.PubMedPubMedCentralCrossRef
22.
Klem ML, Wing RR, McGuire MT, Seagle HM, Hill JO. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66(2):239–46.PubMed
23.
Butryn ML, Phelan S, Hill JO, Wing RR. Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity. 2007;15(12):3091–6.PubMedCrossRef
24.
Bond DS, Phelan S, Leahey TM, Hill JO, Wing RR. Weight loss maintenance in successful weight losers: surgical versus non-surgical methods. Int J Obes. 2009;33(1):173–80.CrossRef
25.
26.
Raynor HA, Jeffery RW, Phelan S, Hill JO, Wing RR. Amount of food group variety consumed in the diet and long-term weight loss maintenance. Obes Res. 2005;13(5):883–90.PubMedCrossRef
27.
Wyatt HR, Grunwald GK, Mosca CL, Klem ML, Wing RR, Hill JO. Long-term weight loss and breakfast in subjects in the National Weight Control Registry. Obes Res. 2002;10(2):78–82.
28.
Raynor DA, Phelan S, Hill JO, Wing RR. Television viewing and long-term weight maintenance: results from the National Weight Control Registry. Obesity. 2006;14(10):1816–24.
29.
Bachman JL, Phelan S, Wing RR, Raynor HA. Eating frequency is higher in weight loss maintainers and normal-weight individuals than in overweight individuals. J Am Diet Assoc. 2011;111(11):1730–4.PubMedPubMedCentralCrossRef
30.
Odom J, Zalesin KC, Washington TL, Miller WW, Hakmeh B, Zaremba DL, et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg. 2010;20:349–56.PubMedCrossRef
31.
Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA. 2010;304(16):1795–802.
32.
Unick JL, Beavers D, Jakicic JM, Kitabchi AE, Knowler WC, Wadden, TA, et al. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the look AHEAD trial. Diabetes Care. 2011;34(10):2152–7.
33.
Leahey TM, Bond DS, Irwin SR, Crowther JH, Wing RR. When is the best time to deliver behavioral intervention to bariatric surgery patients: before or after surgery? Surg Obes Relat Dis. 2009;5(1):99–102.
34.•
Sarwer DB, Moore RH, Spitzer JC, Wadden TA, Raper SE, Williams NN. A pilot study investigating the efficacy of postoperative dietary counseling to improve outcomes after bariatric surgery. Surg Obes Relat Dis. 2012;8(5):561–8. This is a pilot study on the impact of dietary counseling delivered over the first 4 months following bariatric surgery. PubMedCrossRef
35.
Egberts K, Brown WA, Brennan L, O’Brien P. Does exercise improve weight loss after bariatric surgery? A systematic review. Obes Surg. 2011;22(2):335–41.
36.•
Shah M, Snell P, Rao S, Adams-Huet B, Quittner C, Livingston EH, et al. High-volume exercise program in obese bariatric surgery patients: a randomized, controlled trial. Obesity. 2011;19(9):1826–34. This is a pilot study of a postoperative physical activity intervention.
37.•
Kalarchian MA, Marcus MD, Courcoulas AP, Cheng Y, Levine MD, Josbeno D. Optimizing long-term weight control after bariatric surgery: a pilot study. Surg Obes Relat Dis. 2012;8(6):710–5. This is a pilot study of behavioral weight management for patients with suboptimal weight loss 3 years following bariatric surgery.
38.
Chang AK, Fritschi C, Kim MJ. Nurse-led empowerment strategies for hypertensive patients with metabolic syndrome. Contemp Nurse. 2012;42(1):118–28.PubMedCrossRef
39.
40.
Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17(1):37–41.PubMedCrossRef
41.
Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, et al. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns. 2013;93(2):157–68.PubMedCrossRef
42.
Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behavior. New York: The Guildford Press; 1991.
43.
Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12(9):709–23.PubMed
44.
West DS, DiLillo V, Bursac Z, Gore SA, Greene PG. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care. 2007;30(5):1081–7.PubMedCrossRef
45.
West DS, Gorin AA, Subak LL, Foster G, Bragg C, Hecht J, et al. A motivation-focused weight loss maintenance program is an effective alternative to a skill-based approach. Int J Obes. 2011;35:259–69.CrossRef
46.
Wagner EH, Glasgow RE, Bonomi DC, Provost L, MeCulloch D, Carver P, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001;27:63–80.PubMed
47.
Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical Diabetes. 2004;22(3):123–7.CrossRef
48.
Funnell MM, Anderson RM, Ahroni JH. Empowerment and self-management after weight loss surgery. Obes Surg. 2005;15(3):417–22.PubMedCrossRef
49.
Anderson RM, Funnell MM, Butler P, Arnold MS, Fitzgerald J, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care. 1995;18(7):943–9.
50.
Anderson RM, Funnell MM, Aikens JE, Krein SL, Fitzgerald JT, Mwankwo R, et al. Evaluating the efficacy of an empowerment-based self-management consultant intervention: results of a two-year randomized controlled trial. Ther Patient Educ. 2009;1(1):3–11.
51.
Piatt GA, Anderson RM, Brooks MM, Songer T, Siminerio LM, Korytkowski MM, et al. 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: results of a randomized controlled trial. Diabetes Educ. 2010;36(2):301–9.PubMedCrossRef
52.
Anderson RM, Funnell MM, Nwankwo R, Gillard ML, Oh M, Fitzgerald JT. Evaluating a problem-based empowerment program for African americans with diabetes: results of a randomized controlled trial. Ethn Dis. 2005;15(4):671–8.
53.
Kim Y, Pike J, Adams H, Cross D, Doyle C, Foreyt J. Telephone intervention promoting weight-related health behaviors. Prev Med. 2010;50(3):112–7.PubMedCrossRef
54.
Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008;299(10):1139–48.PubMedCrossRef
55.
Perri MG, Limacher MC, Durning PE, Janicke DM, Lutes LD, Bobroff LB. Extended-care programs for weight management in rural communities: the treatment of obesity in underserved rural settings (TOURS) randomized trial. Arch Intern Med. 2008;168(21):2347–54.PubMedPubMedCentralCrossRef
56.
Thomas JG, Bond DS. Review of innovations in digital health technology to promote weight control. Curr Diabetes Rep. 2014;14(5):485.CrossRef
57.
Tate DF, Wing RR, Winett RA. Using Internet technology to deliver a behavioral weight loss program. JAMA. 2001;285(9):1172–7.PubMedCrossRef
58.
Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL. A self-regulation program for maintenance of weight loss. N Engl J Med. 2006;355(15):1563–71.PubMedCrossRef
59.
Turk MW, Yang K, Hravnak MH, Sereika SM, Ewing LJ, Burke LE. Randomized clinical trials of weight loss maintenance: a review. J Cardiovasc Nurs. 2009;24(1):58–80.PubMedPubMedCentralCrossRef
60.
Meenan RT, Stevens VJ, Funk K, Bauck A, Jerome GJ, Lien LF, et al. Development and implementation cost analysis of telephone- and internet-based interventions for the maintenance of weight loss. Int J Technol Assess Health Care. 2009;25(3):400–10.PubMedPubMedCentralCrossRef
61.
Thomas JG, Bond DS, Sarwer DB, Wing RR. Technology for behavioral assessment and intervention in bariatric surgery. Surg Obes Relat Dis. 2011;7(4):548–57.PubMedPubMedCentralCrossRef
62.
Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56–69.
63.
Haapala I, Barengo N, Biggs S, Surakka L, Manninen P. Weight loss by mobile phone: a 1-year effectiveness study. Public Health Nutr. 2009;12(12):2282–391.CrossRef
64.
Shapiro JR, Koro T, Neal Doran N, Thompson S, Sallis JF, Calfas K, et al. Text4Diet: a randomized controlled study using text messaging for weight loss behaviors. Prev Med. 2012;55(5):412–7.
65.
66.
Heber D, Greenway F, Kaplan L, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRef
67.
Padwal R, Li S, Lau D. Long-term pharmacotherapy for obesity and overweight. Cochrane Database of Syst Rev 2003; 4. Art. No: CD004094.
68.
69.
Hemo B, Endevelt R, Porath A, Stampfer M, Shai I. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals. Diabetes Res Clin Pract. 2011;94(2):269–75.PubMedCrossRef
70.
Jensen M, Ryan D, Apovian C, Loria C, Ard J. AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.PubMedCrossRef
71.
Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, et al. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study. Int J Obes. 2007;32(4):692–9.CrossRef
72.
Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 2001;161(2):218–27.PubMedCrossRef
73.
Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA. 2003;289(14):1805–12.PubMedCrossRef
74.
Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111–20.PubMedCrossRef
75.
Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med. 2006;145(2):81–90.PubMedCrossRef
76.
Di Francesco V, Sacco T, Zamboni M, Bissoli L, Zoico E, Mazzali G, et al. Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study. Ann Nutr Metab. 2007;51(1):75–81.PubMedCrossRef
77.
Daniels SR, Long B, Crow S. Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. Pediatrics. 2007;120(1):147–57.CrossRef
78.
79.
Roche Laboratories I. XENICAL-orlistat capsule. Patient package insert. January 2013.
80.
Ziegler O, Sirveaux M, Brunaud L, Reibel N, Quilliot D. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35(6 pt 2):544–57.PubMedCrossRef
81.
Inc. E. BELVIQ (Lorcaserin hydrochloride) tablets, for oral use. Patient package insert. June 2012.
82.
Inc V. Qsymia (phentermine and topiramate extended release) capsules, for oral use. Patient package insert. September 2013.
83.
Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosebraugh C. The FDA’s assessment of two drugs for chronic weight management. N Engl J Med. 2012;367(17):1577–9.PubMedCrossRef
84.
Brethauer SA, Kothari S, Sudan R, Williams B, English WJ, Bregman M, et al. Systematic review on reoperative bariatric surgery: American Society for Metabolic and Bariatric Surgery Revision Task Force. Surg Obes Relat Dis. 2014. doi:10.​1016/​j.​soard.​2014.​02.​014.
85.
Kellogg TA. Revisional bariatric surgery. Surg Clin N Am. 2011;91(6):1353–71.
86.
Moshiri M, Osman S, Robinson TJ, Khandelwai S, Bhargave P, Rohmann CA. Evolution of bariatric surgery: a historical perspective. Am J Roentgenol. 2013;201(1):W40–48.CrossRef
87.
Sarr MG. Reoperative bariatric surgery. Surg Endosc. 2007;21(11):1909–13.
88.
Zundel N, Hernandez JD. Revisional surgery after restrictive procedures for morbid obesity. Surg Laparosc Endosc Percutan Tech. 2010;20(5):338–43.PubMedCrossRef
89.
Schwartz RW, Strodel WE, Simpson WS, Griffen WO. Gastric bypass revision: lessons learned from 920 cases. Surgery. 1988;104(4):806–12.PubMed
90.
Hallowell PT, Stellato TA, Yao DA, Robinson A, Schuster M, Graf KN. Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J Surg. 2009;197(3):391–6.PubMedCrossRef
Metadata
Title
Lifestyle Management for Enhancing Outcomes after Bariatric Surgery
Authors
Melissa Kalarchian
Melanie Turk
Jennifer Elliott
William Gourash
Publication date
01-10-2014
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 10/2014
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-014-0540-y

Other articles of this Issue 10/2014

Current Diabetes Reports 10/2014 Go to the issue

Psychosocial Aspects (KK Hood, Section Editor)

Motivational Interviewing to Promote Adherence Behaviors in Pediatric Type 1 Diabetes

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (EM Venditti, Section Editor)

Weight Loss and Physical Activity for Disease Prevention in Obese Older Adults: an Important Role for Lifestyle Management

Transplantation (A Pileggi, Section Editor)

New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation

Diabetes Epidemiology (NM Maruthur)

Famines in the Last 100 Years: Implications for Diabetes

Microvascular Complications—Neuropathy (D Ziegler, Section Editor)

The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy

Psychosocial Aspects (KK Hood, Section Editor)

Getting a Technology-Based Diabetes Intervention Ready for Prime Time: a Review of Usability Testing Studies
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits